Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review

4 May 2018

Abstract excerpt

Although early aggressive and prolonged treatment with specific antibiotics can extend survival in patients with cystic fibrosis (CF) colonized by opportunistic Pseudomonas aeruginosa (PA), antibiotics fail to eradicate the infecting multidrug-resistant (MDR) PA strains in CF. Century-long research has suggested treating patients with bacteriophages (phages, prokaryotic viruses) naturally hosted by bacteria....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Cystic Fibrosis Research Advances
Share to Vibrio bacteria research studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29780361
DOI: 10.3389/fmicb.2018.00775

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative ReviewPMID 29780361Read ↗

Pseudomonas aeruginosa Bacteriophages and Their Clinical ApplicationsSemantic proximity Read ↗

Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail FormulationSemantic proximity Read ↗

Bacteriophage–Antibiotic Combination Therapy against Pseudomonas aeruginosaSemantic proximity Read ↗

Reduced prevalence of phage defense systems in Pseudomonas aeruginosa strains from cystic fibrosis patientsSemantic proximity Read ↗

Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosisSemantic proximity Read ↗

Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?Semantic proximity Read ↗

Reduced prevalence of phage defense systems in <i>Pseudomonas aeruginosa</i> strains from Cystic Fibrosis PatientsSemantic proximity Read ↗

Novel Therapeutic Strategies Applied to Pseudomonas aeruginosa Infections in Cystic FibrosisSemantic proximity Read ↗

Identification and Functional Insights into New Phage Tail-Like Bacteriocins (PTLBs) Targeting <i>Pseudomonas aeruginosa</i> as new antimicrobialsSemantic proximity Read ↗

Efficacy of a phage cocktail preparation for chronic lung infection with <i>Pseudomonas aeruginosa</i> in miceSemantic proximity Read ↗

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airwaysSemantic proximity Read ↗

<i>Pseudomonas aeruginosa</i> PA5oct jumbo phage impacts planktonic and biofilm population and reduces its host virulenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.